Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry (PA-IPF)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry (PA-IPF) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provide better access of patients with pulmonary fibrosis in all regions of Pennsylvania to standard of care and diagnosis 3) To facilitate the translation of new therapeutic interventions from the bench to the bedside.
| Condition |
|---|
|
Idiopathic Pulmonary Fibrosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry |
| Estimated Enrollment: | 9999 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | November 2050 |
The University of Pittsburgh Medical Center, Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease is the coordination center for the Pennsylvania Idiopathic Pulmonary Fibrosis Statewide Research Registry, the collaborative institutions include: the University of Pennsylvania Health System, Geisinger Health System, and Penn State Milton S. Hershey Medical Center.
The PA-IPF Registry developed into a web site that contains information for patients, health professionals, and families, as well as an Internet-based database that will store information about patients to provide them with guidance about care, research, and support groups close to the area in which they live.
Benefits for membership in the PA-IPF Registry include:
- Staying informed about IPF research news, both nationally and locally.
- Having advance notice of any IPF research in which patients may be eligible to participate.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF)
Inclusion Criteria:
- IPF diagnosis
- Sufficient testing results completed for an IPF Diagnosis (screening script)
- Adults (age > 18 years old)
- Participants who read and comprehend English language
Exclusion Criteria:
- Children
- Prisoner-patients
Contacts and Locations| Contact: Trisha R Black, BA | 1-866-9224IPF | blacktr@upmc.edu |
| Contact: Mindy J Seagriff, BA | 412-802-6860 | seagriffmj@upmc.edu |
| United States, Pennsylvania | |
| Milton S. Hershey Medical Center | Recruiting |
| Hershey, Pennsylvania, United States, 17033 | |
| Contact: Anne Dimmock, B.A. 717-531-2925 adimmock@hmc.psu.edu | |
| Principal Investigator: Rebecca Bascom, MD | |
| Temple University | Recruiting |
| Philadelphia, Pennsylvania, United States, 19140 | |
| Contact: Gayle Jones, RN 215-707-1359 gayle.jones@tuhs.temple.edu | |
| Principal Investigator: Gerard Criner, M.D. | |
| University of Pennsylvania Health System | Recruiting |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Contact: Victoria Fleck 215-662-3115 fleckv@uphs.upenn.edu | |
| Contact: Lisa Gardo, RN 215-615-0276 lisa.gardo@uphs.upenn.edu | |
| Principal Investigator: Gergory Tino, M.D. | |
| Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease | Recruiting |
| Pittsburgh, Pennsylvania, United States, 15213 | |
| Contact: Trisha R Black, B.A. 412-605-1550 blacktr@upmc.edu | |
| Contact: Kathleen O Lindell, PhD 412-802-3274 lindellko@upmc.edu | |
| Principal Investigator: Naftali Kaminski, M.D. | |
| The Center for Health Research at Giesinger Health System | Recruiting |
| Wilkes Barre, Pennsylvania, United States, 18711 | |
| Contact: Rebecca Search, MPH 570-214-9940 rasearch@geisinger.edu | |
| Contact: Mary Ann Blosky, RN 570-214-9544 mblosky@geisinger.edu | |
| Principal Investigator: Paul F Simmonelli, M.D. | |
| Principal Investigator: | Naftali Kaminski, MD | Director, Dorothy P. & Richard P. Simmons Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | Naftali Kaminski, Professor of Medicine, Pathology, Human Genetics and Computational Biology, University of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00540475 History of Changes |
| Other Study ID Numbers: | PRO07040328 |
| Study First Received: | October 3, 2007 |
| Last Updated: | June 22, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Pittsburgh:
|
Idiopathic Pulmonary Fibrosis Interstitial Lung Disease |
Additional relevant MeSH terms:
|
Fibrosis Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis Pathologic Processes |
Lung Diseases Respiratory Tract Diseases Idiopathic Interstitial Pneumonias Lung Diseases, Interstitial |
ClinicalTrials.gov processed this record on May 22, 2013